MTOR and breast cancer: Consistent with the findings of Muranen et al.12, we noticed here that in breast cancer cells, inhibition of PI3K/mTOR signaling by BEZ235 induced upregulation of total protein and phosphorylation levels of EGFR, HER2, HER3, insulin receptor, and IGF-1 receptor.